Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3755865
- 103 Pages
- February 2020
- Healthcare
The global Phosphodiesterase Type 5 (PDE5) Inhibitor market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Phosphodiesterase Type 5 (PDE5) Inhibitor by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Sildenafil
Tadalafil
Avanafil
Vardenafil
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Eli Lilly
Pfizer
Bayer
Novartis AG
Merck
GlaxoSmithKline plc
Roche
AstraZeneca
BaiYunShan General Factory
SK Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
Vectura Group
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Retail Pharmacy
Online Pharmacies
Others
Competitive Landscape:
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Phosphodiesterase Type 5 (PDE5) Inhibitor Industry
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Phosphodiesterase Type 5 (PDE5) Inhibitor
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Phosphodiesterase Type 5 (PDE5) Inhibitor
1.2.2 Downstream
Table Application Segment of Phosphodiesterase Type 5 (PDE5) Inhibitor
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Phosphodiesterase Type 5 (PDE5) Inhibitor Market by Type
3.1 By Type
3.1.1 Sildenafil
Table Major Company List of Sildenafil
3.1.2 Tadalafil
Table Major Company List of Tadalafil
3.1.3 Avanafil
Table Major Company List of Avanafil
3.1.4 Vardenafil
Table Major Company List of Vardenafil
3.2 Market Size
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2019, by Type, in USD Million
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth 2015-2019, by Type, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2019, by Type, in Volume
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast 2020-2025, by Type, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Eli Lilly (Company Profile, Sales Data etc.)
4.1.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.1.2 Eli Lilly Products & Services
4.1.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Pfizer (Company Profile, Sales Data etc.)
4.2.1 Pfizer Profile
Table Pfizer Overview List
4.2.2 Pfizer Products & Services
4.2.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Novartis AG (Company Profile, Sales Data etc.)
4.4.1 Novartis AG Profile
Table Novartis AG Overview List
4.4.2 Novartis AG Products & Services
4.4.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Merck (Company Profile, Sales Data etc.)
4.5.1 Merck Profile
Table Merck Overview List
4.5.2 Merck Products & Services
4.5.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
4.6.1 GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Overview List
4.6.2 GlaxoSmithKline plc Products & Services
4.6.3 GlaxoSmithKline plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Roche (Company Profile, Sales Data etc.)
4.7.1 Roche Profile
Table Roche Overview List
4.7.2 Roche Products & Services
4.7.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 AstraZeneca (Company Profile, Sales Data etc.)
4.8.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.8.2 AstraZeneca Products & Services
4.8.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 BaiYunShan General Factory (Company Profile, Sales Data etc.)
4.9.1 BaiYunShan General Factory Profile
Table BaiYunShan General Factory Overview List
4.9.2 BaiYunShan General Factory Products & Services
4.9.3 BaiYunShan General Factory Business Operation Conditions
Table Business Operation of BaiYunShan General Factory (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 SK Chemicals (Company Profile, Sales Data etc.)
4.10.1 SK Chemicals Profile
Table SK Chemicals Overview List
4.10.2 SK Chemicals Products & Services
4.10.3 SK Chemicals Business Operation Conditions
Table Business Operation of SK Chemicals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Teva Pharma (Company Profile, Sales Data etc.)
4.11.1 Teva Pharma Profile
Table Teva Pharma Overview List
4.11.2 Teva Pharma Products & Services
4.11.3 Teva Pharma Business Operation Conditions
Table Business Operation of Teva Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Dong-A ST (Company Profile, Sales Data etc.)
4.12.1 Dong-A ST Profile
Table Dong-A ST Overview List
4.12.2 Dong-A ST Products & Services
4.12.3 Dong-A ST Business Operation Conditions
Table Business Operation of Dong-A ST (Sales Revenue, Cost, Gross Margin)
4.13 Metuchen Pharma (Company Profile, Sales Data etc.)
4.13.1 Metuchen Pharma Profile
Table Metuchen Pharma Overview List
4.13.2 Metuchen Pharma Products & Services
4.13.3 Metuchen Pharma Business Operation Conditions
Table Business Operation of Metuchen Pharma (Sales Revenue, Cost, Gross Margin)
4.14 Seoul Pharma (Company Profile, Sales Data etc.)
4.14.1 Seoul Pharma Profile
Table Seoul Pharma Overview List
4.14.2 Seoul Pharma Products & Services
4.14.3 Seoul Pharma Business Operation Conditions
Table Business Operation of Seoul Pharma (Sales Revenue, Cost, Gross Margin)
4.15 Vectura Group (Company Profile, Sales Data etc.)
4.15.1 Vectura Group Profile
Table Vectura Group Overview List
4.15.2 Vectura Group Products & Services
4.15.3 Vectura Group Business Operation Conditions
Table Business Operation of Vectura Group (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Revenue 2015-2019, by Company, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Revenue Share in 2019, by Company, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Volume 2015-2019, by Company, in Volume
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration, in 2019
Figure Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Market Concentration, in 2019
Figure Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor MMarket Concentration, in 2019
Figure South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration, in 2019
Figure Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Hospital, 2015-2019, in USD Million
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Hospital, 2015-2019, in Volume
6.1.2 Demand in Retail Pharmacy
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Retail Pharmacy, 2015-2019, in USD Million
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Retail Pharmacy, 2015-2019, in Volume
6.1.3 Demand in Online Pharmacies
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Online Pharmacies, 2015-2019, in USD Million
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Online Pharmacies, 2015-2019, in Volume
6.1.4 Demand in Others
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Others, 2015-2019, in USD Million
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Others, 2015-2019, in Volume
6.1.5 Demand in Competitive Landscape:
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Competitive Landscape:, 2015-2019, in USD Million
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Demand in Competitive Landscape:, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Demand Forecast 2020-2025, by Application, in USD Million
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth 2020-2025, by Application, in USD Million
Figure Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share in 2025, by Application, in USD Million
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Demand Forecast 2020-2025, by Application, in Volume
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth 2020-2025, by Application, in Volume
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Production 2015-2019, by Region, in USD Million
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2019, by Region, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share 2015-2019, by Region, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2019, by Region, in Volume
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in USD Million
Figure North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in USD Million
Figure Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in USD Million
Figure South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast 2020-2025, by Region, in USD Million
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of Phosphodiesterase Type 5 (PDE5) Inhibitor
Table Application Segment of Phosphodiesterase Type 5 (PDE5) Inhibitor
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2025, by Application, in USD Million
Table Major Company List of Tadalafil
Table Major Company List of Avanafil
Table Major Company List of Vardenafil
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2019, by Type, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2019, by Type, in Volume
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast 2020-2025, by Type, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast 2020-2025, by Type, in Volume
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline plc Overview List
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BaiYunShan General Factory Overview List
Table Business Operation of BaiYunShan General Factory (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SK Chemicals Overview List
Table Business Operation of SK Chemicals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharma Overview List
Table Business Operation of Teva Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dong-A ST Overview List
Table Business Operation of Dong-A ST (Sales Revenue, Cost, Gross Margin)
Table Metuchen Pharma Overview List
Table Business Operation of Metuchen Pharma (Sales Revenue, Cost, Gross Margin)
Table Seoul Pharma Overview List
Table Business Operation of Seoul Pharma (Sales Revenue, Cost, Gross Margin)
Table Vectura Group Overview List
Table Business Operation of Vectura Group (Sales Revenue, Cost, Gross Margin)
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Revenue 2015-2019, by Company, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Volume 2015-2019, by Company, in Volume
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Demand Forecast 2020-2025, by Application, in USD Million
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Demand Forecast 2020-2025, by Application, in Volume
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Market Growth 2020-2025, by Application, in Volume
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share in 2025, by Application, in Volume
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Production 2015-2019, by Region, in USD Million
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Production 2015-2019, by Region, in Volume
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2019, by Region, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share 2015-2019, by Region, in USD Million
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market 2015-2019, by Region, in Volume
Table Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Share 2015-2019, by Region, in Volume
Table North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table North America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
Table Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table Europe Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
Table South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table South America Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size 2015-2019, by Country, in Volume
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast 2020-2025, by Region, in USD Million
Table Phosphodiesterase Type 5 (PDE5) Inhibitor Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
